Published in Antimicrob Agents Chemother on May 01, 1997
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev (2012) 4.39
Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother (2000) 3.22
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2000) 2.17
Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.87
Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol (1999) 1.81
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother (2000) 1.65
Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother (2000) 1.63
SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2002) 1.60
Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol (2008) 1.59
Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.53
SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.45
Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob Agents Chemother (2002) 1.34
High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol (2004) 1.27
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2008) 1.18
The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother (2005) 1.17
Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother (2004) 1.17
Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain. J Bacteriol (2012) 1.16
Quinolone resistance: much more than predicted. Front Microbiol (2011) 1.14
Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol (2010) 1.14
The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog (2011) 1.12
Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis. J Clin Microbiol (2013) 1.10
SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2009) 1.09
Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun (2003) 1.07
Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF. Antimicrob Agents Chemother (2004) 1.05
The intrinsic resistome of bacterial pathogens. Front Microbiol (2013) 1.05
Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J Biol Chem (2009) 1.03
Functional characterization of the RNA chaperone Hfq in the opportunistic human pathogen Stenotrophomonas maltophilia. J Bacteriol (2012) 0.95
A function of SmeDEF, the major quinolone resistance determinant of Stenotrophomonas maltophilia, is the colonization of plant roots. Appl Environ Microbiol (2014) 0.93
Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates. J Korean Med Sci (2013) 0.91
Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother (2004) 0.90
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2000) 0.86
Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China. Front Microbiol (2014) 0.86
Short-sighted evolution of bacterial opportunistic pathogens with an environmental origin. Front Microbiol (2014) 0.86
Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia. Appl Environ Microbiol (2013) 0.84
Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol (2014) 0.83
The Inactivation of intrinsic antibiotic resistance determinants widens the mutant selection window for quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2012) 0.80
The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2015) 0.79
Identification and characterization of a serious multidrug resistant Stenotrophomonas maltophilia strain in China. Biomed Res Int (2015) 0.78
The inactivation of RNase G reduces the Stenotrophomonas maltophilia susceptibility to quinolones by triggering the heat shock response. Front Microbiol (2015) 0.76
Whole-Genome Sequencing Identifies Emergence of a Quinolone Resistance Mutation in a Case of Stenotrophomonas maltophilia Bacteremia. Antimicrob Agents Chemother (2015) 0.75
Vitamin K3 Induces the Expression of the Stenotrophomonas maltophilia SmeVWX Multidrug Efflux Pump. Antimicrob Agents Chemother (2017) 0.75
Predictive Studies Suggest that the Risk for the Selection of Antibiotic Resistance by Biocides Is Likely Low in Stenotrophomonas maltophilia. PLoS One (2015) 0.75
Alterations in soil microbial communities caused by treatments with penicillin or neomycin. Environ Sci Pollut Res Int (2017) 0.75
Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science (1994) 11.18
Multidrug efflux pumps of gram-negative bacteria. J Bacteriol (1996) 9.86
Proton-dependent multidrug efflux systems. Microbiol Rev (1996) 8.81
Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol (1995) 8.41
Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem Sci (1994) 5.21
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother (1989) 5.09
Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol (1994) 4.91
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother (1994) 4.87
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol (1995) 2.99
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol (1995) 2.55
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother (1994) 2.10
OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.83
Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol Lett (1996) 1.67
Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia. Antimicrob Agents Chemother (1994) 1.61
Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother (1991) 1.61
Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob Agents Chemother (1992) 1.52
Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother (1996) 1.49
Quinolone antimicrobial agents. Annu Rev Med (1992) 1.36
Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J Clin Microbiol (1995) 1.23
Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. Infection (1995) 1.19
Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1996) 1.19
Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med (1996) 1.11
Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention. J Antimicrob Chemother (1993) 1.01
The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology (1994) 1.01
Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect (1995) 0.91
Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin. J Antimicrob Chemother (1994) 0.90
Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis (1994) 0.87
Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia. J Hosp Infect (1995) 0.82
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2000) 2.17
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother (1991) 2.12
Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol (1999) 1.71
Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother (2000) 1.63
Environmental selection of antibiotic resistance genes. Environ Microbiol (2001) 1.50
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50
Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology (1999) 1.38
Microcin-mediated interactions between Klebsiella pneumoniae and Escherichia coli strains. J Gen Microbiol (1984) 1.32
Pressure induced effects on the Fermi surface of superconducting 2H-NbSe2. Phys Rev Lett (2005) 1.32
H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. J Bacteriol (1997) 1.09
Aminoglycoside resistance mediated by the bifunctional enzyme 6'-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase. Front Biosci (1999) 1.05
Metal accumulation and vanadium-induced multidrug resistance by environmental isolates of Escherichia hermannii and Enterobacter cloacae. Appl Environ Microbiol (1998) 0.98
Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proc Natl Acad Sci U S A (1997) 0.95
In vitro plasmid-encoded resistance to quinolones. FEMS Microbiol Lett (1997) 0.93
Epidemiology of aerobactin production in Enterobacteriaceae. Ann Inst Pasteur Microbiol (1988) 0.84
Growth of Escherichia coli in acetate as a sole carbon source is inhibited by ankyrin-like repeats present in the 2',5'-linked oligoadenylate-dependent human RNase L enzyme. FEMS Microbiol Lett (1997) 0.83
Towards an ecological approach to antibiotics and antibiotic resistance genes. Clin Microbiol Infect (2009) 0.83
Finding universal correlations between cationic disorder and low field magnetoresistance in FeMo double perovskite series. Phys Rev Lett (2001) 0.82
Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study. J Hypertens (2001) 0.81
[Low-grade B cell gastric lymphoma originated in mucosa-associated lymphoid tissue. Relationship of tumor cells with the marginal zone and monocytoid B lymphocytes. An immunohistochemical and ultrastructural study]. Med Clin (Barc) (1990) 0.81
Isolation, characterization, and mode of action on Escherichia coli strains of microcin D93. Antimicrob Agents Chemother (1986) 0.81
[Validity of 6 indirect methods to assess treatment compliance in arterial hypertension]. Med Clin (Barc) (1994) 0.80
Shigella sonnei bacteremia in an elderly diabetic patient. Eur J Clin Microbiol Infect Dis (1988) 0.79
Microcin 15n: a second antibiotic from Escherichia coli LP15. J Antibiot (Tokyo) (1983) 0.79
[Influence of the place of measurement and of the person who performs it on the control and diagnosis of arterial hypertension]. Rev Clin Esp (1994) 0.79
Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48. Rev Esp Enferm Dig (2009) 0.78
Acquisition of antibiotic resistance plasmids in vivo by extraintestinal Salmonella spp. J Antimicrob Chemother (1987) 0.78
AQP-1 association with body fluid loss in 10-km runners. Int J Sports Med (2011) 0.77
Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ (1995) 0.77
Cardiodepressor effects of 7-O-demethylisothalicberine, bisbenzylisoquinoline alkaloid isolated from Berberis chilensis. Arch Med Res (1993) 0.77
Analgesic efficacy and bioavailability of ketorolac in postoperative pain: a probability analysis. Arch Med Res (2000) 0.77
[Validity of four indirect methods which evaluate therapeutic compliance for arterial hypertension]. Rev Clin Esp (1993) 0.77
Effects of 7-O-demethylisothalicberine, a bisbenzylisoquinoline alkaloid of Berberis chilensis, on electrical activity of frog cardiac pacemaker cells. Gen Pharmacol (1989) 0.76
Large cell calcifying Sertoli cell tumour of the testis. Histopathology (1995) 0.76
pH modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase. J Antimicrob Chemother (1996) 0.75
[Inhibition of pump and permeability mechanisms]. Rev Esp Quimioter (1999) 0.75
Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response. Aliment Pharmacol Ther (2001) 0.75
Wavelength-compensated time-sequential multiplexed color joint transform correlator. Appl Opt (2010) 0.75
Super resolution imaging achieved by using on-axis interferometry based on a Spatial Light Modulator. Opt Express (2013) 0.75
[Incidence and prevalence of periodontal diseases]. ADM (1987) 0.75
[Application of DNA probes in clinical microbiology]. Enferm Infecc Microbiol Clin (1989) 0.75
[Auricular dissociation. Unilateral auricular arrest]. Medicina (B Aires) (1981) 0.75
Protein synthesis by synaptosomes from the head ganglion of the squid, Loligo pealli. Acta Cient Venez (1976) 0.75
Crystal and magnetic structure of the double perovskite Sr2CoUO6: a neutron diffraction study. Dalton Trans (2004) 0.75
[Pericardial diseases. Evaluation of current methods of non-invasive tests]. Medicina (B Aires) (1983) 0.75
Ultrastructure of fish cells involved in cellular defences against Saprolegnia infections: evidence of non-leucocytic nature. Dis Aquat Organ (1998) 0.75
[A retrospective study of HBsAG carriers in the blood bank of Navarra]. Rev Med Univ Navarra (1991) 0.75
[Serum folate and vitamin B12 levels in patients undergoing maintenance dialysis]. Sangre (Barc) (1982) 0.75
[Validity of epidemiologic criteria in the detection of hypertension]. Rev Clin Esp (1994) 0.75
[Bilateral anorchia: a well-defined clinical entity]. Rev Clin Esp (1975) 0.75
[Transitory or intermittent hemi-blocks]. Rev Esp Cardiol (1972) 0.75
[A study of clinical response to antibiotic treatment in subjects with chronic bacterial prostatitis]. Rev Esp Quimioter (2004) 0.75
[Klippel-Feil syndrome and interventricular communication]. Rev Esp Cardiol (1970) 0.75
[Pericardial diseases. Clinical study]. Medicina (B Aires) (1983) 0.75
[Trophic and functional changes of the pancreas induced by chronic truncal vagotomy]. Acta Gastroenterol Latinoam (1981) 0.75
Surprising resistivity decrease in manganites with constant electronic density. J Phys Condens Matter (2013) 0.75
Early surgical treatment of urine leak in renal transplantation. Transplant Proc (1996) 0.75
[Mesosystolic clicks and apical telesystolic murmurs]. Rev Esp Cardiol (1971) 0.75
Heavy metals, chlorine and antibiotic resistance in Escherichia coli isolates from ambulatory patients. J Chemother (1990) 0.75
[Diagnostic and prognostic value of the quantification of serum 1-elastase levels in acute pancreatitis]. Rev Esp Enferm Apar Dig (1987) 0.75
Comparison of intravenous ketorolac and butorphanol on ventilatory function and analgesia of pain after surgery. Proc West Pharmacol Soc (1994) 0.75
Canine segmental liver autotransplantation: an experimental training and research model. Transplant Proc (1996) 0.75
Prognostic value of tumoral ploidy in a series of spanish patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet (2000) 0.75
[A four year study of therapeutical observation of patients with hypertension]. Rev Clin Esp (1993) 0.75
[Comparative study of transferrin measurement and total iron binding capacity (author's transl)]. Sangre (Barc) (1981) 0.75
[Quality of drug prescriptions by the Spanish internal medicine services]. An Med Interna (1996) 0.75
[Factors involved in the hypertensive patient non-compliance with treatment]. Med Clin (Barc) (1994) 0.75
[Angina caused by subclavian-coronary steal in patients revascularized with internal mammary artery]. Rev Esp Cardiol (1998) 0.75
[Scheduled biliary surgery and antibiotic prophylaxis. Is its use always justified?]. An Med Interna (1997) 0.75
Environmental fungus flora in quail-breeding farms. Avian Dis (1981) 0.75
[Epidemiology of urologic pediatric emergencies in our hospital, 1990]. Actas Urol Esp (1993) 0.75
[Statistical study on fetuses of more than 4,000 grams]. Acta Obstet Ginecol Hisp Lusit (1971) 0.75
[Renal transplant and valvular prosthesis]. Rev Clin Esp (1982) 0.75
[Occlusal trauma]. ADM (1974) 0.75
[Determination of glucose-6-phosphate dehydrogenase deficiency to prevent possible drug-induced hemolysis]. Rev Cubana Med Trop (1991) 0.75